What is a stock summary page? Click here for an overview.
Business Description
Sequent Scientific Ltd
ISIN : INE807F01027
Compare
Compare
Traded in other countries / regions
512529.India IPO Date
2016-03-10Description
Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.72 | |||||
| Debt-to-EBITDA | 3.18 | |||||
| Interest Coverage | 1.95 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.91 | |||||
| Beneish M-Score | -2.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.1 | |||||
| 3-Year EBITDA Growth Rate | -36.5 | |||||
| 3-Year Book Growth Rate | -3.5 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.75 | |||||
| 9-Day RSI | 34.88 | |||||
| 14-Day RSI | 37.16 | |||||
| 3-1 Month Momentum % | -13.55 | |||||
| 6-1 Month Momentum % | -30.45 | |||||
| 12-1 Month Momentum % | 26.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | |||||
| Quick Ratio | 0.96 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 146.27 | |||||
| Days Sales Outstanding | 79.59 | |||||
| Days Payable | 111.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -1.06 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.95 | |||||
| Operating Margin % | 7.3 | |||||
| Net Margin % | 0.77 | |||||
| FCF Margin % | -0.01 | |||||
| ROE % | 1.78 | |||||
| ROA % | 0.76 | |||||
| ROIC % | 6.96 | |||||
| 3-Year ROIIC % | -90.17 | |||||
| ROC (Joel Greenblatt) % | 11.7 | |||||
| ROCE % | 9.05 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 296.83 | |||||
| PE Ratio without NRI | 239.97 | |||||
| Shiller PE Ratio | 49.38 | |||||
| PS Ratio | 2.33 | |||||
| PB Ratio | 5.01 | |||||
| Price-to-Tangible-Book | 8.77 | |||||
| Price-to-Operating-Cash-Flow | 111.55 | |||||
| EV-to-EBIT | 43.47 | |||||
| EV-to-Forward-EBIT | 26.01 | |||||
| EV-to-EBITDA | 24.58 | |||||
| EV-to-Forward-EBITDA | 17.25 | |||||
| EV-to-Revenue | 2.53 | |||||
| EV-to-Forward-Revenue | 1.77 | |||||
| EV-to-FCF | -18352.85 | |||||
| Price-to-GF-Value | 1.13 | |||||
| Price-to-Projected-FCF | 4.38 | |||||
| Price-to-Median-PS-Value | 0.89 | |||||
| Price-to-Graham-Number | 8.49 | |||||
| Earnings Yield (Greenblatt) % | 2.29 | |||||
| FCF Yield % | -0.01 | |||||
| Forward Rate of Return (Yacktman) % | 13.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sequent Scientific Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 15,074.4 | ||
| EPS (TTM) (₹) | 0.46 | ||
| Beta | 2.1 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.33 | ||
| Volatility % | 64.91 | ||
| 14-Day RSI | 37.16 | ||
| 14-Day ATR (₹) | 7.522531 | ||
| 20-Day SMA (₹) | 142.154 | ||
| 12-1 Month Momentum % | 26.14 | ||
| 52-Week Range (₹) | 92.05 - 240.7 | ||
| Shares Outstanding (Mil) | 249.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sequent Scientific Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sequent Scientific Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sequent Scientific Ltd Frequently Asked Questions
What is Sequent Scientific Ltd(NSE:SEQUENT)'s stock price today?
The current price of NSE:SEQUENT is ₹132.79. The 52 week high of NSE:SEQUENT is ₹240.70 and 52 week low is ₹92.05.
When is next earnings date of Sequent Scientific Ltd(NSE:SEQUENT)?
The next earnings date of Sequent Scientific Ltd(NSE:SEQUENT) is 2025-05-15 Est..
Does Sequent Scientific Ltd(NSE:SEQUENT) pay dividends? If so, how much?
Sequent Scientific Ltd(NSE:SEQUENT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers